GIANT BIOGENE (02367) spent HKD 14.3966 million to repurchase 400,000 shares on December 23rd.
Giant Biology (02367) announced on December 23, 2025, that the company had spent 14.3966 million Hong Kong dollars to repurchase 400,000 shares.
GIANT BIOGENE (02367) announced that on December 23, 2025, the company spent HK$14.3966 million to repurchase 400,000 shares.
Related Articles
RECBIO-B(02179): Electing Xu Haoyu as Chairman.
HANS GP Holdings (00554) issued a total of 249 million share options.
XINYI ENERGY (03868) plans to acquire all the equity of Jinzhai Xinyi Wind Power for 62 million yuan.
RECBIO-B(02179): Electing Xu Haoyu as Chairman.
HANS GP Holdings (00554) issued a total of 249 million share options.
XINYI ENERGY (03868) plans to acquire all the equity of Jinzhai Xinyi Wind Power for 62 million yuan.
RECOMMEND
